| Patricia J Bohart, MD | |
|
3901 Normal Blvd Ste 201, Lincoln, NE 68506-5250 | |
| (402) 261-4017 | |
| (402) 261-4137 |
| Full Name | Patricia J Bohart |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 33 Years |
| Location | 3901 Normal Blvd Ste 201, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760437610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 18843 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blue Valley Behavioral Health Inc | 3971403668 | 12 |
News Archive
Treatments using antibiotics should stop as soon as possible to prevent patients passing the "tipping point" of becoming resistant to their effects, new research has shown.
In a new study published in Disease Models & Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Cedars-Sinai neuroscience researchers are studying whether extensive changes in lifestyle among patients with mild cognitive impairment can slow the progression of Alzheimer's disease.
› Verified 7 days ago
| Entity Name | Blue Valley Behavioral Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316019508 PECOS PAC ID: 3971403668 Enrollment ID: O20040109000728 |
News Archive
Treatments using antibiotics should stop as soon as possible to prevent patients passing the "tipping point" of becoming resistant to their effects, new research has shown.
In a new study published in Disease Models & Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Cedars-Sinai neuroscience researchers are studying whether extensive changes in lifestyle among patients with mild cognitive impairment can slow the progression of Alzheimer's disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia J Bohart, MD 1123 N 9th St, Beatrice, NE 68310-2041 Ph: (402) 228-3386 | Patricia J Bohart, MD 3901 Normal Blvd Ste 201, Lincoln, NE 68506-5250 Ph: (402) 261-4017 |
News Archive
Treatments using antibiotics should stop as soon as possible to prevent patients passing the "tipping point" of becoming resistant to their effects, new research has shown.
In a new study published in Disease Models & Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Cedars-Sinai neuroscience researchers are studying whether extensive changes in lifestyle among patients with mild cognitive impairment can slow the progression of Alzheimer's disease.
› Verified 7 days ago
Stephanie Sutton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 550 N 19th St, Lincoln, NE 68588 Phone: 402-472-5000 | |
Dr. Walter J Duffy, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8101 O St, Suite 300, Lincoln, NE 68510 Phone: 402-476-6060 Fax: 402-476-6809 | |
Soa Yuc Lee, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-489-3802 | |
Dianna M Clyne, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4444 South 86th St, Suite 102, Lincoln, NE 68526 Phone: 402-476-7557 Fax: 402-769-9912 | |
Michael William Vavra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2222 S 16th St Ste 340, Lincoln, NE 68502 Phone: 402-483-8534 Fax: 402-483-8531 | |
Zakaria Siddiqui, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2221 S 17th St, Suite 202, Lincoln, NE 68502 Phone: 402-483-8555 Fax: 402-483-8554 | |
Ana Luisa Delgado, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7441 O St Ste 104, Lincoln, NE 68510 Phone: 402-853-0993 Fax: 402-853-0197 |